Skip to content
10-Q

Quarterly Report

HEMAGEN DIAGNOSTICS INC

0001445866-12-000352

← back to feed
Filed
May 15, 2012 12:00 AM ET
Period of report
—

On SEC.gov

Filing index ↗

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2012 · May 14, 2012 15.5M sh
Shares Diluted Q2 2012 · Mar 31, 2012 15.49M sh
Shares Diluted Q2 2012 · Mar 31, 2012 15.49M sh
Shares Diluted Q2 2012 · Mar 31, 2011 15.47M sh
Shares Diluted Q2 2012 · Mar 31, 2011 15.47M sh
Capex Q2 2012 · Mar 31, 2012 −$71.94K
Capex Q2 2012 · Mar 31, 2011 −$31.48K
Operating Cash Flow Q2 2012 · Mar 31, 2012 −$324.87K
Operating Cash Flow Q2 2012 · Mar 31, 2011 −$62.15K
Cash And Equivalents Q2 2012 · Mar 31, 2012 $86.88K
Cash And Equivalents Q2 2012 · Sep 30, 2011 $213.61K
Cash And Equivalents Q2 2012 · Mar 31, 2011 $299.41K
Cash And Equivalents Q2 2012 · Sep 30, 2010 $151.74K
Stockholders Equity Q2 2012 · Mar 31, 2012 −$3.24M
Stockholders Equity Q2 2012 · Sep 30, 2011 −$2.69M
Current Liabilities Q2 2012 · Mar 31, 2012 $1.79M
Current Liabilities Q2 2012 · Sep 30, 2011 $1.53M
Total Liabilities Q2 2012 · Mar 31, 2012 $5.84M
Total Liabilities Q2 2012 · Sep 30, 2011 $5.58M
Current Assets Q2 2012 · Mar 31, 2012 $2.16M
Current Assets Q2 2012 · Sep 30, 2011 $2.45M
Total Assets Q2 2012 · Mar 31, 2012 $2.59M
Total Assets Q2 2012 · Sep 30, 2011 $2.89M
Eps Diluted Q2 2012 · Mar 31, 2012 −$0.02
Eps Diluted Q2 2012 · Mar 31, 2012 −$0.04
Eps Diluted Q2 2012 · Mar 31, 2011 −$0.02
Eps Diluted Q2 2012 · Mar 31, 2011 −$0.04
Eps Basic Q2 2012 · Mar 31, 2012 −$0.02
Eps Basic Q2 2012 · Mar 31, 2012 −$0.04
Eps Basic Q2 2012 · Mar 31, 2011 −$0.02
Eps Basic Q2 2012 · Mar 31, 2011 −$0.04
Sga Expense Q2 2012 · Mar 31, 2012 $452.42K
Sga Expense Q2 2012 · Mar 31, 2012 $1.11M
Sga Expense Q2 2012 · Mar 31, 2011 $586.39K
Sga Expense Q2 2012 · Mar 31, 2011 $1.19M
Rd Expense Q2 2012 · Mar 31, 2012 $25.31K
Rd Expense Q2 2012 · Mar 31, 2012 $26.05K
Rd Expense Q2 2012 · Mar 31, 2011 $1.15K
Rd Expense Q2 2012 · Mar 31, 2011 $2.53K
Net Income Q2 2012 · Mar 31, 2012 −$243.64K
Net Income Q2 2012 · Mar 31, 2012 −$612.2K
Net Income Q2 2012 · Mar 31, 2011 −$366.33K
Net Income Q2 2012 · Mar 31, 2011 −$550.51K
Operating Income Q2 2012 · Mar 31, 2012 −$127.2K
Operating Income Q2 2012 · Mar 31, 2012 −$381.91K
Operating Income Q2 2012 · Mar 31, 2011 −$272.01K
Operating Income Q2 2012 · Mar 31, 2011 −$363.47K
Gross Profit Q2 2012 · Mar 31, 2012 $350.53K
Gross Profit Q2 2012 · Mar 31, 2012 $757.86K
Gross Profit Q2 2012 · Mar 31, 2011 $315.53K
Gross Profit Q2 2012 · Mar 31, 2011 $825.34K
Cost Of Revenue Q2 2012 · Mar 31, 2012 $760.77K
Cost Of Revenue Q2 2012 · Mar 31, 2012 $1.46M
Cost Of Revenue Q2 2012 · Mar 31, 2011 $902.18K
Cost Of Revenue Q2 2012 · Mar 31, 2011 $1.77M
Revenue Q2 2012 · Mar 31, 2012 $1.11M
Revenue Q2 2012 · Mar 31, 2012 $2.22M
Revenue Q2 2012 · Mar 31, 2011 $1.22M
Revenue Q2 2012 · Mar 31, 2011 $2.59M